Side-by-side comparison of AI visibility scores, market position, and capabilities
Irvine CA structural heart devices (NYSE: EW) at $5.44B 2024 revenue; 60% TAVR global share, EVOQUE tricuspid +88% in Q4, Critical Care sold to BD for $4.2B, JenaValve acquisition expanding to aortic regurgitation.
Edwards Lifesciences Corporation is an Irvine, California-based structural heart disease and hemodynamic monitoring technology company — publicly traded on the New York Stock Exchange (NYSE: EW) as an S&P 500 Healthcare component — designing, developing, and manufacturing devices for heart valve replacement, transcatheter heart valve therapy, and cardiac critical care through approximately 15,800 employees in 100+ countries. In fiscal year 2024, Edwards reported total revenue of $5.44 billion (+8.6% year-over-year), driven by its dominant Transcatheter Aortic Valve Replacement (TAVR) franchise commanding approximately 60% global market share and 70%+ US market share. The Transcatheter Mitral and Tricuspid Therapies (TMTT) segment demonstrated exceptional growth, with Q4 TMTT revenue reaching $105 million (+88% year-over-year), as the EVOQUE tricuspid replacement system gained commercial momentum. In 2024, Edwards executed a major strategic transformation: divesting its Critical Care segment (hemodynamic monitoring) to Becton Dickinson for $4.2 billion — using the proceeds to fund two acquisitions: JenaValve Technology ($1.2B combined, expanding TAVR to high-risk patients with aortic regurgitation) and Endotronix. The company concentrates its entire focus on structural heart disease therapies.
Advertising holding company with $15.7B FY2024 revenue; $13.5B IPG merger announced Dec 2024 to create world's largest ad group; Omni AI data platform; BBDO, DDB, TBWA flagship agencies.
Omnicom Group is one of the world's largest holding companies for advertising, marketing, and communications services, founded in 1986 through the merger of BBDO, Doyle Dane Bernbach, and Needham Harper Worldwide, and headquartered in New York City. The company trades on NYSE (OMC) and reported $15.7 billion in revenues for FY2024, employing approximately 100,000 professionals across more than 70 countries. CEO John Wren has led Omnicom since 1997, navigating the digital transformation of advertising from traditional media to programmatic, social, and AI-driven marketing. In December 2024, Omnicom announced the planned acquisition of Interpublic Group (IPG) in an all-stock deal valued at approximately $13.5 billion, which if completed would create the world's largest advertising holding company with over $25 billion in combined revenues.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.